The KEGG pathway analysis of the pharmacological targets reveals several key pathways, including the neuroactive ligand–receptor interaction, the AGE-RAGE signaling pathway implicated in diabetic complications, and pathways associated with lipid metabolism and atherosclerosis. The gene discussed is RENBP; the disease is atherosclerosis.